BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17649732)

  • 21. [Anaplastic carcinoma of the thyroid--problems in diagnosis and treatment].
    Tahara H; Shiba E; Koyama H; Iwanaga T; Terasawa T; Nakano S; Wada A; Matsuda M
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):73-9. PubMed ID: 3701168
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anaplastic carcinoma of the thyroid: diagnosis and treatment].
    Giuffrida D; Lavenia G; Aiello RA; Di Blasi C; Gambera G; Pappalardo A; Petralia G; Ursino M; Failla G
    Clin Ter; 2001; 152(4):255-61. PubMed ID: 11725619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients.
    Besic N; Hocevar M; Zgajnar J; Pogacnik A; Grazio-Frkovic S; Auersperg M
    Langenbecks Arch Surg; 2005 Jun; 390(3):203-8. PubMed ID: 15599758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoma of the thyroid gland.
    Shimaoka K; Sako K; Friedman M; Bakshi S; Rao U
    Int Adv Surg Oncol; 1980; 3():111-55. PubMed ID: 6926738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anaplastic thyroid tumor: retrospective analysis of 12 cases].
    Martins TD; Carrilho F; Leitão P; Lemos MC; Campos MV; Geraldes E; Carvalheiro M
    Acta Med Port; 2004; 17(5):349-51. PubMed ID: 16197840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
    Are C; Shaha AR
    Ann Surg Oncol; 2006 Apr; 13(4):453-64. PubMed ID: 16474910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Medullary carcinoma of the thyroid (author's transl)].
    Trotoux J; Pinel J
    Ann Otolaryngol Chir Cervicofac; 1979; 96(1-2):65-86. PubMed ID: 464519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anaplastic carcinoma of the thyroid: the diagnosis and treatment (author's transl)].
    Kasai N; Kamata S; Katoh T; Tsuchida Y; Uchida M; Sakamoto A; Ogawa S
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1263-74. PubMed ID: 7334263
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prognostic factors in differentiated thyroid carcinoma].
    Nóvoa Mogollón FJ; Limiñana Canal JM; Carrillo Domínguez A; Cabrera Galván JJ; Báez Marrero O; Betancor León P
    Rev Clin Esp; 1993 May; 192(9):441-6. PubMed ID: 8516511
    [No Abstract]   [Full Text] [Related]  

  • 31. [Poorly-differentiated thyroid carcinoma: morphological verification and differential diagnosis].
    Friedman MV
    Vopr Onkol; 2006; 52(1):47-53. PubMed ID: 16715703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medullary carcinoma of the thyroid. Natural history, diagnosis and therapy].
    Decensi A; Guarneri D; Boccardo F
    Minerva Med; 1986 Nov; 77(44):2131-5. PubMed ID: 2878394
    [No Abstract]   [Full Text] [Related]  

  • 33. High-risk thyroid cancer. Prolonged survival with early multimodality therapy.
    Durie BG; Hellman D; Woolfenden JM; O'Mara R; Kartchner M; Salmon SE
    Cancer Clin Trials; 1981; 4(1):67-73. PubMed ID: 7214663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer.
    Nix PA; Nicolaides A; Coatesworth AP
    Int J Clin Pract; 2006 Jan; 60(1):80-4. PubMed ID: 16409432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma.
    Orita Y; Sugitani I; Amemiya T; Fujimoto Y
    Surgery; 2011 Dec; 150(6):1212-9. PubMed ID: 22136842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors determining survival in differentiated thyroid cancer.
    Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
    J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease.
    O'Neill JP; O'Neill B; Condron C; Walsh M; Bouchier-Hayes D
    J Laryngol Otol; 2005 Aug; 119(8):585-91. PubMed ID: 16102210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
    Sugitani I; Fujimoto Y; Yamamoto N
    Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
    Elliott DD; Sherman SI; Busaidy NL; Williams MD; Santarpia L; Clayman GL; El-Naggar AK
    Hum Pathol; 2008 Jan; 39(1):15-20. PubMed ID: 17949783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of differentiated thyroid carcinoma: a retrospective study.
    De Falco M; Oliva G; Ragusa M; Misso C; Parmeggiani D; Sperlongano P; Calzolari F; Puxeddu E; Misso C; Marzano LA; Barbarisi A; Parmeggiani U; Avenia N
    G Chir; 2008 Apr; 29(4):152-8. PubMed ID: 18419979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.